Le Lézard
Classified in: Health
Subject: FDA

EXPANDING INNOVATIONS, INC. ANNOUNCES FDA APPROVAL OF X-PAC EXPANDABLE LATERAL CAGE SYSTEM


MOUNTAIN VIEW, Calif., Feb. 21, 2023 /PRNewswire/ -- Expanding Innovations, Inc. (EI), a spinal implant company that designs NON-SCREW based expandable cage technology, announced today that the company has received 510(k) clearance from the FDA for the X-PAC Expandable Lateral Cage System (X-PAC LLIF). This approval marks a significant addition to the company's expandable product portfolio which also includes the company's flagship X-PAC Expandable Posterior Cage System (X-PAC TLIF).

Dr. K. Brandon Strenge, Orthopaedic Institute of Western Kentucky, said, "The X-PAC Expandable Lateral Cage System is the first implant I have seen that addresses the core principals of lateral lumbar interbody fusion. The maximized posterior expansion facilitates indirect decompression, the open architecture ensures a bridging bone fusion, and the multiple lordotic options allow proper implant selection for restoration of sagittal balance. These benefits, coupled with the ability to insert the cage at a nominal height, then dial it up via controlled expansion, make X-PAC Lateral an exciting and beneficial technology to offer my patients moving forward."

Expanding Innovations, Inc. (EI) will feature the new X-PAC Expandable Lateral and X-PAC Expandable Posterior Cage Systems at these upcoming 2023 events:

About Expanding Innovations, Inc.

Expanding Innovations, Inc. (EI) is committed to facilitating better patient care by solving the most challenging clinical problems faced by today's spine surgeons. EI recognized the need to develop a next-generation expandable interbody cage technology that would eliminate the incidence of post-op cage collapse. Rising to the challenge, EI developed a revolutionary, NON-SCREW based expandable cage that surgeons and patients can count on. By replacing the traditional inner screw with a powerful, continuous lifting mechanism, supported by robust, unidirectional locking teeth, the X-PAC Cage alleviates the concern of post-op cage collapse. The Expanding Innovations (EI) portfolio includes the X-PAC Expandable Lateral & Posterior Cage Systems, as well as active development of X-PAC ALIF, ATP & ENDO platforms. For more information, please visit www.expandinginnovations.com.

SOURCE Expanding Innovations


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: